According to the Global Times newspaper, the agreement stimulated the shares in the Chinese firm’s stock markets and local observers value it as positive because it expands the treatment options for the disease, just when the country suffers a rise in infections with the Omicron variant. of the SARS-CoV-2 coronavirus.
His signing came after China’s drug regulators approved the importation and use of Paxlovid on February 11 to administer it to adult patients with moderate and mild symptoms of Covid-19 who are at risk of worsening.
That group includes the elderly with diabetes, heart disease and serious lung problems.
But the authorities urged doctors who prescribe it to monitor its interaction with other medications and also to investigate in depth how it acts in the human body.
Paxlovid helps to reduce the symptoms of the disease, the risks of hospitalization and death in three days. So far it is licensed for use in more than 50 countries around the world.
China gave the drug the green light amid strong outbreaks of Covid-19 with the Omicron that it is experiencing in almost twenty provinces and in Hong Kong, where in recent days there have been up to a record 50,000 new patients daily.
For local experts, the situation is more worrying because the largest number of infections are asymptomatic and different sectors show a certain degree of fatigue in the implementation of the zero tolerance strategy against the pathology that the country maintains.
This mechanism includes the requirement of PCR tests to access many events and travel from a region considered at risk of infections, permanent monitoring of body temperature in public places and the immediate confinement of entire communities in the presence of the virus.
The mechanism is currently applied in the bubble activated for the Beijing 2022 Winter Paralympic Games and the Government has no plans to adjust it until it has new measures that allow it to prevent imported SARS-CoV-2 infections.
This Friday, China added 1,369 confirmed and asymptomatic cases, thus maintaining the upward trend shown in the last week.
In general, the country has a record of at least 8,639 deaths and 380,238 patients in its mainland, Hong Kong, Macao and Taiwan since the emergence of Covid-19 and the pathogen that causes it in December 2019.
About 90 percent of the population is vaccinated against the disease.